Optimization of time interval for the measurement of plasma lipids for cardiovascular disease risk assessment

CONCLUSIONS: Testing patients for lipids who have a higher baseline risk more often could identify high-risk patients sooner, allowing for earlier and more effective therapeutic intervention.PMID:38252511 | DOI:10.1080/14737159.2024.2306127

Source: Expert Review of Molecular Diagnostics - January 22, 2024 Category: Laboratory Medicine Authors: Maureen Sampson Anna Wolska Rafael Zubiran Justine Cole Marcelo Amar Alan T Remaley Source Type: research